Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
04/29/2004 | US20040082577 Amino methyl imidazoles as C5a receptor modulators |
04/29/2004 | US20040082572 Benzodiazepine derivatives as app modulators |
04/29/2004 | US20040082571 Substituted piperazines |
04/29/2004 | US20040082568 Tetrazolylpropionamides as inhibitors of Abeta protein production |
04/29/2004 | US20040082566 Pyrrolidine sulfonamides |
04/29/2004 | US20040082561 Antilipemic agents; anticholesterol agents |
04/29/2004 | US20040082559 Vitronectin receptor antagonists |
04/29/2004 | US20040082551 Novel pyrazoles and their use as p38 kinase inhibitors |
04/29/2004 | US20040082542 Useful as modulators of interaction between receptor for advanced glycated end products (RAGE) and its ligands, such as advanced glycated end products (AGEs), S100/calgranulin/EN-RAGE, beta-amyloid and amphoterin |
04/29/2004 | US20040082497 For treatment of growth hormone deficiency/polycystic ovary syndrome autoimmune/inflammatory disease |
04/29/2004 | US20040082475 Herbicides |
04/29/2004 | CA2501547A1 Substituted indoles and their use as hcv inhibitors |
04/29/2004 | CA2501539A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
04/29/2004 | CA2501418A1 Novel compounds |
04/29/2004 | CA2500320A1 Novel compounds with antibacterial activity |
04/28/2004 | EP1413579A1 Imidazoline derivatives, process for the preparation thereof and pharmaceutical compositions containing them |
04/28/2004 | EP1413576A2 Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
04/28/2004 | EP1412348A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres |
04/28/2004 | EP1412338A1 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists |
04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
04/28/2004 | EP1412028A1 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
04/28/2004 | EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
04/28/2004 | EP1411944A1 Sulfonamide derivatives as gamma secretase inhibitors |
04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
04/28/2004 | EP1411933A1 Alpha-ketoamide derivatives as cathepsin k inhibitors |
04/28/2004 | EP1411928A1 Viral polymerase inhibitors |
04/28/2004 | EP1411881A2 5HT sb 2C /sb RECEPTOR MODULATORS |
04/28/2004 | CN1492864A Pyrazolyl pyrimidines |
04/28/2004 | CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor |
04/28/2004 | CN1491949A Pyridazine-3-one derivatives, their use, and intermediate preparing them |
04/28/2004 | CN1491941A Heterobicyclic sulfonamide derivative and sulfonic ester derivative |
04/28/2004 | CN1147486C 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
04/27/2004 | US6727364 Antiinflammatory agents |
04/27/2004 | US6727273 Therapy for osteoporosis, anticancer agents |
04/27/2004 | US6727266 Substituted tryptophan derivatives |
04/27/2004 | US6727257 Hypotensive agents for intraocular pressure; anticholesterol agents; relaxing urinary tract tissue; benign prostatic hyperplasia, impotency, and cardiovascular disorders; antiarrhythmia agents |
04/27/2004 | US6727255 Brain, nervous system and psychological disorders |
04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
04/27/2004 | US6727246 Enhancement of cognition and memory in human diseases such as alzheimer's |
04/27/2004 | US6727206 Substituted aryl ketones |
04/27/2004 | US6727053 Forms an azomethine dye upon a coupling reaction with an oxidized product of a developing agent |
04/27/2004 | US6727041 Optical recording media |
04/27/2004 | CA2136745C Heterocyclically disubstituted sulphonylamino(thio)carbonyl compounds |
04/23/2004 | CA2445817A1 Novel derivatives of imidazoline, process for their preparation and pharmaceutical compositions containing them |
04/22/2004 | WO2004033451A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives |
04/22/2004 | WO2004033435A1 Quinazolinone derivatives useful as anti-hyperalgesic agents |
04/22/2004 | WO2004033434A1 Pyrazole compounds for treatment of neurodegenerative disorders |
04/22/2004 | WO2004033432A1 Novel pyrazole compounds having antifungal activity |
04/22/2004 | WO2004033431A2 Hydroxypyrazoles for use against metabolic-related disorders |
04/22/2004 | WO2004033422A2 Modulation of anxiety through blockade of anandamide hydrolysis |
04/22/2004 | WO2004032871A2 Piperazine and piperazinone inhibitors of factor xa |
04/22/2004 | WO2004032861A2 Hexahydro-benzimidazolone compounds useful as anti-inflammatory agents |
04/22/2004 | WO2004032846A2 Triazolone and triazolethione derivatives |
04/22/2004 | WO2004032834A2 Thrombin inhibitors |
04/22/2004 | WO2004022544A8 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
04/22/2004 | WO2004016597A3 Protein kinase inhibitors and uses thereof |
04/22/2004 | WO2004014300A3 Tyrosine kinase inhibitors |
04/22/2004 | WO2004002986A3 Novel benzimidazole derivatives |
04/22/2004 | WO2003072541A3 Chemical compounds |
04/22/2004 | WO2003057214A8 Imidazolidin-2,4-dione derivatives as non-peptide somatostatin receptor ligands |
04/22/2004 | WO2002074767A8 Metalloproteinase inhibitors |
04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
04/22/2004 | WO2002074748A8 Metalloproteinase inhibitors |
04/22/2004 | US20040077877 Jun n-terminal kinase inhibitors |
04/22/2004 | US20040077860 Quinoxaline derivative; light-emitting diode, light-emitting electrochemical cell, or a photodetector |
04/22/2004 | US20040077852 Para-phenylenediamine derivatives containing a pyrrolidyl group, and use of these derivatives for coloring keratin fibers |
04/22/2004 | US20040077851 Receptor selective cannabimimetic aminoalkylindoles |
04/22/2004 | US20040077705 Cyclopentyl indole derivatives |
04/22/2004 | US20040077701 Pyrazole derivates for treatment of osteoporosis, breast and endometrial cancers, atherosclerosis, and Alzheimer*s disease |
04/22/2004 | US20040077693 Integrin receptor inhibitors |
04/22/2004 | US20040077685 Analogs of thalidomide as potential angiogenesis inhibitors |
04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
04/22/2004 | US20040077668 Compounds, compositins, and methods |
04/22/2004 | US20040077667 Quinazolinone derivatives |
04/22/2004 | US20040077662 Compounds, methods and compositions |
04/22/2004 | US20040077657 HT3 Receptor antagonists; amyotrophic lateral sclerosis, premenstrual tension, obsessive-compulsive disorder; Parkinson*s, Alzheimer*s, and Huntington*s disease; memory, eating, psychological, and nervous system disorders |
04/22/2004 | US20040077653 GABAA (gamma-aminobutyric acid) receptor modulators; anxiolytic, antidepresant agents; attention deficit disorder, Alzheimer*s disease treatment; central nervous systmem disorders |
04/22/2004 | US20040077650 Cannabinoid receptor ligands and uses thereof |
04/22/2004 | US20040077648 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
04/22/2004 | US20040077619 Calcium receptor modulating agents |
04/22/2004 | US20040077019 Tagging compounds and process for use in aida libraries |
04/22/2004 | US20040076673 Oral pharmaceutical composition containing a block copolymer |
04/22/2004 | DE10296560T5 Benzotriazole und deren Verwendung als UV-Lichtstabilisatoren Benzotriazoles and their use as UV-light stabilizers |
04/22/2004 | DE10247680A1 New benzotriazole-1-carboxylic acid amide or ester compounds, are hormone-sensitive lipase inhibitors useful for treating non-insulin dependent diabetes or diabetic syndrome |
04/22/2004 | DE10153346A1 Substituierte Indole Substituted indoles |
04/22/2004 | CA2501529A1 Quinazolinone derivatives useful as anti-hyperalgesic agents |
04/22/2004 | CA2501506A1 Modulation of anxiety through blockade of anandamide hydrolysis |
04/22/2004 | CA2501352A1 Antimicrobial [3.1.0] bicyclic oxazolidinone derivatives |
04/21/2004 | EP1411049A1 Estrogen Agonists/Antagonists |
04/21/2004 | EP1411047A1 Intercalators having affinity for DNA and methods of use |
04/21/2004 | EP1409546A2 Protease inhibitor conjugates and antibodies useful in immunoassay |
04/21/2004 | EP1409481A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
04/21/2004 | EP1409480A1 Pyrrolo-indole and pyrrolo-quinoline derivatives as prodrugs for tumour treatment |
04/21/2004 | EP1409466A2 Hiv protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
04/21/2004 | EP1409463A1 N-heterocyclic inhibitors of tnf-alpha expression |
04/21/2004 | EP1409455A1 Prostaglandin analogues-as ep4 receptor agonists |
04/21/2004 | EP1409450A1 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
04/21/2004 | EP1409024A1 Macrocyclic metal complexes and use thereof for production of conjugates with biomolecules |